Golimumab 1 mg per kg
CR014188
Phase 3 small_molecule terminated
Quick answer
Golimumab 1 mg per kg for Colitis, Ulcerative is a Phase 3 program (small_molecule) at Janssen Cilag International NV with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Janssen Cilag International NV
- Indication
- Colitis, Ulcerative
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated